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INTRODUCTION
Chronic cough, usually defined as cough persisting for 3
weeks or longer, is sometimes a vexing medical problem. The
prevalence of chronic cough among nonsmoking adults is
reported to range from 14 to 23% (1, 2). The most common
causes of chronic cough are postnasal drip (PND), asthma,
gastroesophageal reflux (GER), and drugs such as angiotensin
converting enzyme inhibitors (ACEI) (3). 
However, the etiological diagnosis is not easy in some pa-
tients especially if the obvious clues are not present in symp-
toms, radiography, or spirometry. In some cases, a specific
cause of cough cannot be identified despite thorough inves-
tigation. There is no consensus about the management of not
only idiopathic chronic cough (ICC) but also chronic cough
refractory to specific treatment or recurring after stopping
medication. We presume that identification of the mecha-
nisms of chronic cough would permit the development of
successful treatment modalities.
Bronchial hyperresponsiveness (BHR) (4), eosinophilic
bronchial inflammation (5), or abnormal bronchial intraepi-
thelial nerve (6) have been observed in some patients with
chronic cough. Enhanced cough sensitivity, which is inde-
pendent of BHR, was reported in chronic cough due to GER
and ACEI- induced cough (7), cough after upper respiratory
infection (URI) (8), and ICC (7, 9). This enhanced cough re-
flex triggered by various chemical and mechanical factors has
been regarded as a common and central pathophysiology of
chronic cough by many researchers (4, 7-10). With all of those
results, however, the exact mechanism of chronic cough has
not been clarified.
Because cough receptors are predominant along the pharyn-
golaryngeal area (11), abnormalities in this extrathoracic air-
way might be important in the pathogenetic mechanism of
chronic cough. Recently, extrathoracic airway hyperrespon-
siveness (EAHR) during histamine inhalation was observed
in the patients with asthma-like symptoms (12), GER (13),
and ACEI-induced cough (14). We hypothesized that sen-
sory hypersensitivity of extrathoracic airway characterized by
increased cough sensitivity and EAHR might induce chronic
cough especially in the subjects not to have any definite clues
suggesting abnormalities of lower airway and in the patients
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Cough Sensitivity and Extrathoracic Airway Responsiveness to Inhaled
Capsaicin in Chronic Cough Patients
Enhanced cough response has been frequently observed in chronic cough. Re-
cently, extrathoracic airway constriction to inhaled histamine was demonstrated
in some chronic cough patients. However, relation between extrathoracic airway
hyperresponsiveness (EAHR) and cough sensitivity determined by capsaicin
inhalation is unclear in each etiological entity of chronic cough. Seventy-seven
patients, with dry cough persisting for 3 or more weeks, normal spirometry and
chest radiography, and 15 controls, underwent methacholine bronchial provoca-
tion test and capsaicin cough provocation test. Elicited cough number and flow-
volume curve was examined after inhalation of capsaicin to evaluate cough sen-
sitivity and EAHR. Thirty-three patients, with postnasal drip, showed normal ex-
trathoracic airway responsiveness, and 27 of them showed normal cough sensi-
tivity to capsaicin. Cough sensitivity was enhanced in 14 patients with cough vari-
ant asthma (CVA) who showed bronchial hyperresponsiveness; EAHR to inhaled
capsaicin was present in 12 of them. The remaining 30 patients were tentatively
diagnosed as idiopathic chronic cough (ICC). Eleven ICC patients showed en-
hanced cough sensitivity and EAHR to inhaled capsaicin while 19 patients showed
normal values. These results indicate that cough sensitivity is closely related with
extrathoracic airway responsiveness during capsaicin provocation in some chronic
cough patients. EAHR and enhanced cough sensitivity to inhaled capsaicin may
be a part of mechanism developing chronic cough. 
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Accepted : 16 July 2002showing inappropriate cough response such as cough variant
asthma (CVA).
To the best of our knowledge, there has been no study on
the relationship between cough sensitivity and extrathoracic
airway responsiveness on capsaicin inhalation, which is the
most commonly used method to determine cough sensitivity
and is known to stimulate cough receptors effectively with-
out influences on lower airway such as bronchocontriction.
In this study, we investigated cough sensitivity and extratho-
racic airway responsiveness to inhaled capsaicin in chronic
cough of diverse causes to characterize the underlying patho-
physiology. 
MATERIALS AND METHODS 
Subjects
Patients complaining chronic dry cough lasting 3 or more
weeks, who did not have symptoms of dyspnea or purulent
sputum, were recruited from the outpatient department of
our institution. All of the patients were nonsmokers, had
normal chest radiographs, normal spirometry [both forced
expiratory volume for 1 sec (FEV1) and forced vital capacity:
(FVC) >80% of predicted values], and did not have upper
respiratory tract infection in the preceding 2 months. No pa-
tients have taken antihypertensive medications such as ACEIs
and beta-blockers. Exclusion criteria was other chronic or sys-
temic illness, pregnancy, and intake of any medication within
1 week before the study. Controls were 15 normal nonsmok-
ing healthy volunteers.
Methacholine bronchial provocation test
Methacholine bronchial provocation was performed by use
of a dosimeter-controlled jet nebulizer with increasing doses
of methacholine from 0.625 to 25 mg/mL. Each dose of me-
thacholine was inhaled by 5 slow and vital capacity breaths.
At one and 3 min after each set of inhalation, spirometry was
recorded. The interval between one dose and the next was 5
min. The concentration causing a 20% fall in FEV1 from base-
line (PC20) was used as the threshold of bronchial responsive-
ness and BHR was defined when PC20 was less than 25 mg/dL.
Capsaicin cough provocation test and determination
of cough sensitivity and extrathoracic airway respon-
siveness
Subjects inhaled a single breath of saline and doubling con-
centrations of capsaicin (Sigma, St. Louis, Mo, U.S.A.) rang-
ing from 0.5 to 250  M/L at about 1.5-min intervals. Each
inhalation was controlled by the use of a dosimeter and jet
nebulizer. The number of cough in response to each concen-
tration of capsaicin was counted by the investigator during
and 30 sec after inhalation and recording of flow-volume
loop was performed after each inhalation.
In the control group, the lowest concentration of capsaicin
that elicited at least 5 consecutive coughs (C5) was over 64
M/L in all subjects. Based on these results, enhanced cough
sensitivity was defined when C5 was less than 64  M/L. 
With regard to extrathoracic airway responsiveness, the cap-
saicin concentration causing a 20% fall in peak inspiratory
flow (PIF) from baseline (PC20PIF) was used as a threshold of
extrathoracic airway constriction. Capsaicin inhalation was
continued until 20% fall of PIF occurred or capsaicin con-
centration reached to 250  M/L. In addition, the flow-vol-
ume curve was carefully observed to detect a pattern of vari-
able extrathoracic airway obstruction that showed a reduced
PIF, a flattened configuration of the mid-portion of the inspi-
ratory flow-volume curve, and absence of significant change
in pulmonary function in the expiratory phase. 
Control subjects never showed any significant extrathoracic
airway narrowing up to 250  M/L of capsaicin concentration.
According to the results from control subjects, EAHR was
arbitrarily defined when PC20PIF was less than 250  M/L and
a pattern of variable extrathoracic airway obstruction was in-
duced simultaneously.
Statistical analysis
The data are presented as mean±standard deviation. Com-
parisons of data between groups were made by chi-square test
and Kruskal Wallis test. Correlations were calculated using
Pearson’s correlation test. A p-value <0.05 was considered
significant.
RESULTS
Causative disorders of chronic cough
The patients with PND-associated cough were classified
by absence of BHR to inhaled methacholine and having one
or more of the following criteria; any symptoms suggesting
PND such as throat discomfort, radiological evidence such
as the findings of opacity, air-fluid level, or mucoperiosteal
thickening of paranasal sinuses, and good response to anti-
histamines and decongestants for 2 weeks (symptom scores
after treatment decreased to less than 50% than before treat-
ment measured by visual analogue scale). CVA was defined
by the presence of BHR to inhaled methacholine and absence
of any evidence of other diseases. Diagnostic criteria of GER
were clinical histories such as inducing cough at supine posi-
tion, having epigastric soreness, reflux symptoms or past medi-
cal history of peptic ulcers, and response to treatment to 2
weeks’ therapeutic trial with H2 blocker. However, there was
no patient definitely diagnosed as having a GER associated
cough. The remaining patients with persistent unexplained
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PND-associated cough was diagnosed in 33 patients. Four-
teen patients showed BHR and were classified into CVA. ICC
was diagnosed in 30 patients. The airway characteristics of
patients and control subjects are summarized in Table 1. 
Cough sensitivity and extrathoracic airway hyper-
responsiveness
Six of 33 PND patients showed enhanced cough sensitiv-
ity and all 33 patients showed normal EAHR to inhaled cap-
saicin. Enhanced cough sensitivity was observed in all 14
CVA patients and EAHR was present in 12 thereof. Patients
with ICC were divided into two groups in relation to cough
sensitivity to inhaled capsaicin, i.e., 11 patients with enhanced
cough sensitivity and 19 patients with normal. All ICC pa-
tients with enhanced cough sensitivity had EAHR to inhaled
capsaicin, but those with normal cough sensitivity did not
show EAHR (Table 1, Fig. 1). 
Values of C5 were closely related to PC20PIF in all subjects
who showed both enhanced cough sensitivity and EAHR to
inhaled capsaicin such as the patients with CVA and some of
ICC (r=0.633, p<0.0001). In patients with CVA who showed
both EAHR to inhaled capsaicin and BHR to inhaled metha-
choline, no significant correlation between PC20 and PC20PIF
(Fig. 2). 
After capsaicin cough provocation tests, no subjects showed
a significant (>20%) decrease of FEV1. 
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Age (yr) 44.3±14.4 38.0±15.1 51.4±11.3 40.8±14.5 29.4±3.5 <0.01
Sex (M/F) 10/23 6/8 4/7 8/11 5/10 NS
bFEV1(% pred) 104±14 99±8 108±18 104±12 95±12 NS
pcFEV1(% pred) 101±13 95±8 104±13 102±12 92±13 NS
PC20 (mg/dL) >25 4.36±4.5 >25 >25 >25
ECS/NCS (n) 6/27 14/0 11/0 0/19 0/15
EAHR (+/-) 0/33 12/2 11/0 0/19 0/15








Table 1. Characteristics of chronic cough patients
PND, postnasal drip; CVA, cough variant asthma; ICC, idiopathic chronic cough; ECS, enhanced cough sensitivity; NCS, normal cough sensitivity;
bFEV1, baseline FEV1; pcFEV1, FEV1 after capsaicin provocation test; % pred, percent of predicted value; PC20, methacholine provocation concen-


























Fig. 1. Distribution of cough sensitivity and extrathoracic airway
responsiveness to inhaled capsaicin in chronic cough patients of
various causes. PND, patients with postnasal drip; CVA, patients
with cough variant asthma; ICC-ECS, patients with idiopathic
chronic cough showing enhanced cough sensitivity; ICC-NCS,
patients with idiopathic chronic cough showing normal cough
sensitivity; PC20PIF, capsaicin provocation concentration causing
20% fall of peak inspiratory flow; C5, lowest capsaicin concentra-
tion inducing at least 5 coughs; area below horizontal line, pres-
ence of extrathoracic airway hyperresponsiveness to inhaled
capsaicin; area left sided from vertical line, enhanced cough
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Fig. 2. Relationship between bronchial responsiveness to inhaled
methacholine and extrathoracic airway responsiveness to inhaled
capsaicin in patients with cough variant asthma. PC20, methacho-
line provocation concentration causing 20% fall of forced expira-
tory volume for 1 sec;  PC20PIF, same as in Fig. 1.
PC20 ( M/L)DISCUSSION
The results of this study demonstrate that EAHR to in-
haled capsaicin in some etiological entities of chronic cough
such as CVA and ICC was closely related to enhanced cough
sensitivity. There was no correlation be-tween extrathoracic
airway responsiveness to inhaled capsaicin and bronchial re-
sponsiveness to inhaled methacholine. Although it is not
clear whether the extrathoracic airway constriction is a direct
cause or an epiphenomenon, upper airway sensory hypersen-
sitivity independent of lower airway pathology might be one
of important mechanisms inducing cough in some entities
of chronic cough.
We have observed that enhanced cough induction and in-
spiratory upper airway flow limitation occurred simultane-
ously during capsaicin inhalation in most patients with CVA.
A group of ICC patients also showed upper airway sensory
hypersensitivity, i.e., enhanced cough sensitivity and EAHR
to inhaled capsaicin. Therefore, they should not be consid-
ered to have habitual or psychogenic coughs. Chronic cough
in PND associated with sinusitis is suggested to be caused
by mechanical irritations of cough receptors with normal sen-
sitivity. All these results indicate the variety of cough sensi-
tivity, extrathoracic airway responsiveness, and bronchial re-
sponsiveness in chronic cough, which might be managed dif-
ferently.
Recently, the possibility of upper airway abnormalities in
the mechanism of chronic cough has been suggested by Bucca
et al. (12), who reported EAHR to inhaled histamine in pa-
tients having asthma-like symptoms without BHR. They
also demonstrated both EAHR and enhanced cough sensitivi-
ty to inhaled histamine in chronic cough induced by GER
(13) and ACEI (14). The results of our study further support
these findings.
Some investigators argued that EAHR to histamine could
not be implicated as a single unifying mechanism of chron-
ic cough (15). However, in their study, many chronic cough
patients had both rhinitis and GER, which could represent
different cough sensitivity, respectively. In addition, capsaicin
used in our study directly stimulates cough receptors, and in
contrast to histamine, it does not induce bronchoconstriction
in humans (16, 17). Therefore, our method using capsaicin
inhalation may be more appropriate for evaluating upper air-
way abnormalities.
In this study, EAHR and enhanced cough sensitivity to in-
haled capsaicin was important and the only abnormal find-
ing in one subtype of ICC patients. This EAHR was related
not to BHR but to enhanced cough sensitivity. These results
may indicate that upper airway sensory hypersensitivity could
be the most important mechanism eliciting cough in this
subtype of ICC patients. Chronic cough in ICC patients with
normal cough sensitivity could be psychogenic. Therefore,
capsaicin test may be useful to differentiate psychogenic cough
from pathological ICC. However, further studies are needed
to clarify this. 
The exact mechanism inducing enhanced cough sensitivity
has not yet been elucidated. In eosinophilic bronchitis with-
out asthma as Gibson et al. had defined (5), inhaled corticos-
teroid could improve the cough and sputum eosinophilia (18)
and normalize enhanced cough sensitivity (19). Because we
did not perform bronchoscopic biopsy or induced sputum
analysis, we could not exclude this entity in our ICC patients
representing enhanced cough sensitivity. However, consid-
ering that patients with typical asthma have shown normal
cough sensitivity (20), it is not reasonable to presume that
bronchial eosinophilic inflammation per se would be relevant
to enhanced cough sensitivity. Until now, the main site of
pathology for the enhanced cough sensitivity could not be
determined. In addition, the exact pathogenesis of EAHR is
presently unknown although some investigators have report-
ed that the edema and constriction of the pharynx and glot-
tis seen at laryngoscopy after histamine inhalation in patients
with EAHR suggest the activation of local reflexes having
cough receptors as the afferent pathway and skeletal muscles,
glands, and vessels as the efferent pathway (21). Further stud-
ies are needed to clarify the definite mechanisms of both ICC
and EAHR and their association.
There was no definite group of GER-associated cough in
our study. However, considering that 2 weeks’ treatment is
too short to observe any therapeutic benefit on that, some
patients with ICC showing enhanced cough sensitivity might
have had GER-associated cough. In that case, the mechanism
of GER-associated cough that has not yet been clarified may
be associated with upper airway sensory hypersensitivity. 
In this study, we measured PIF to test extrathoracic airway
responsiveness and a 20% decline in PIF from the baseline
value was used as an index to define EAHR to inhaled cap-
saicin, while the provocation concentration of histamine asso-
ciated with a 25% fall in the maximal mid-inspiratory flow
was used as a criterion of extrathoracic airway narrowing in
other studies (12, 14). There was a report that symptoms of
extrathoracic airway obstruction such as stridor and dyspnea
were significantly improved according to 20-30% increase
of PIF in patients with reversible extrathoracic airway obstruc-
tion (22). Also, PIF is a very simple method to detect inspi-
ratory flow limitation when a pattern of variable extratho-
racic airway obstruction is observed in the flow-volume curve.
Therefore, it is considered that PC20PIF could be a convenient
and reasonable index to detect EAHR to inhaled capsaicin.
We divided our chronic cough patients into the enhanced
cough sensitivity group and normal cough sensitivity group
on the basis of data from control subjects by using the value
of C5. The PC20PIF and the criterion of determining enhanced
cough sensitivity used in this study are totally arbitrary indices
and further studies are needed to determine the accuracy and
usefulness of these parameters. 
There has been a controversy about cough sensitivity in
PND. Some investigators have observed normal cough sen-
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ported enhanced cough sensitivity (23). In contrast to the
results of our study, Bucca et al. (24) detected EAHR on his-
tamine inhalation in most sinusitis patients. In our study, we
have observed normal cough sensitivity and extrathoracic air-
way responsiveness to inhaled capsaicin in presumed PND-
associated cough. The reasons for these discrepancies are large-
ly unknown. While patients having typical symptoms of
rhinosinusitis were recruited in Bucca’s study, our patients
complained chronic dry cough despite having some mild and
atypical evidences of PND-associated rhinosinusitis. These
different characteristics of patients might have contributed
to this discrepancy. However, further studies are needed to
clarify it.
In conclusion, there is a close relationship between cough
sensitivity and extrathoracic airway responsiveness during
capsaicin provocation test. It is suggested that extrathoracic
airway sensory hypersensitivity may be one of mechanisms
developing some subtypes of chronic cough.
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